Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People's Republic of China. The company's products include Vastatin Calcium Tablets (Nile), Trimetazidine Hydrochloride capsules, Fanle type I and II tablets, Azathioprine tablets, Amiodarone Hydrochloride tablets, Hydroxyurea tablets, Colchicine tablets, etc. It also offers biological peptide products, food and beverages, cosmetics, and other products. The company was founded in 1980 and is based in Beijing, the People's Republic of China.
Stock data | 2024 | Change |
---|---|---|
Price | $0.34742327735958306 | N/A |
Market Cap | $752.16M | N/A |
Shares Outstanding | 2.16B | N/A |
Employees | 1.08K | N/A |